Apollo Hospitals Q4 results today: What to expect
Apollo Hospitals is expected to post healthy growth in core earnings for the quarter ended March 2024 due to improved ARPOB (average revenue per occupied bed) and Healthco operations. The company will announce its results later today in the evening.
Net profit for the fourth quarter is likely to grow up to 68% year-on-year, according to various analyst estimates, while net sales are expected to rise 13% year-on-year.
Analysts are baking in 11% year-on-year sales growth in the hospitals segment in 4QFY24, while HealthCo sales to grow 14% year-on-year, driven by growth in pharmacy distribution sales on account of the store expansion as well as traction in 24/7.
Investors may watch out for the GMV outlook in Apollo 24/7 and updates on capacity expansions at Pune, Hyderabad, Kolkata and Bengaluru are the key monitorables.
Here's what analysts expect from Apollo Hospitals
Kotak Equities
For AHLL, we forecast 16% year-on-year sales growth in 4QFY24, led by strong growth across diagnostics and specialty care segments. Overall, we expect APHS' revenues to grow 13% year-on-year (flat quarter-on-quarter) in 4QFY24.
We build in 8% year-on-year growth in hospitals EBITDA with EBITDA margin at 23.7% (-70 bps year-on-year). We expect operating spends (including ESOP costs) in 24/7 to decline by 1.5% quarter-on-quarter to Rs 153 crore in 4QFY24. Resultantly, we expect Apollo Healthco to report marginal EBITDA of Rs 2 crore. We expect consolidated EBITDA margin to remain flat quarter-on-quarter at 12.7%.
Motilal Oswal
Sale
